BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19170966)

  • 1. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations.
    Rangel-Santos A; Wakim VL; Jacob CM; Pastorino AC; Cunha JM; Collanieri AC; Niemela JE; Grumach AS; Duarte AJ; Moraes-Vasconcelos D; Oliveira JB
    Scand J Immunol; 2009 Feb; 69(2):169-73. PubMed ID: 19170966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China.
    An Y; Xiao J; Jiang L; Yang X; Yu J; Zhao X
    Scand J Immunol; 2010 Jul; 72(1):50-6. PubMed ID: 20591076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
    Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
    Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome.
    Zhu X; Chung I; O'Gorman MR; Scholl PR
    Clin Immunol; 2001 Jun; 99(3):334-9. PubMed ID: 11358428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
    Groeneweg M; Lankester AC; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
    DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
    Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
    Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
    J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.
    Bajorath J; Seyama K; Nonoyama S; Ochs HD; Aruffo A
    Protein Sci; 1996 Mar; 5(3):531-4. PubMed ID: 16509032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.
    Prasad ML; Velickovic M; Weston SA; Benson EM
    J Clin Pathol; 2005 Jan; 58(1):90-2. PubMed ID: 15623492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.
    Ramachandran R; Krishnan Y; Singh P; Kumar A; Mohanty A
    Immunogenetics; 2023 Apr; 75(2):191-194. PubMed ID: 36478253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
    García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
    Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
    Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis of hyper IgM deficiency - CD40L mutations.
    Thusberg J; Vihinen M
    Protein Eng Des Sel; 2007 Mar; 20(3):133-41. PubMed ID: 17307885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two children with severe recurrent infections and the X-linked hyper-IgM syndrome].
    Groeneweg M; Hartwig NG; Poerink-Stockschläder AB; Schweizer JJ; Bijleveld CM; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1024-8. PubMed ID: 12811975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency.
    Tahara M; Pergolizzi RG; Kobayashi H; Krause A; Luettich K; Lesser ML; Crystal RG
    Nat Med; 2004 Aug; 10(8):835-41. PubMed ID: 15273748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM.
    Ferrari S; Giliani S; Insalaco A; Al-Ghonaium A; Soresina AR; Loubser M; Avanzini MA; Marconi M; Badolato R; Ugazio AG; Levy Y; Catalan N; Durandy A; Tbakhi A; Notarangelo LD; Plebani A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12614-9. PubMed ID: 11675497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
    Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
    Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
    Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
    Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.